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In the United Kingdom, 53 percent of women with symptomatic breast cancer and 27 percent of those with screen-detected breast cancer are treated surgically with mastectomy.1 The imme-diate breast reconstruction rate was 21 percent at the time of the UK National Mastectomy and 
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Background: The authors investigated aesthetic outcome and patient satisfac-
tion in women who have undergone deep inferior epigastric artery perfora-
tor (DIEP) flap reconstruction in the setting of postmastectomy radiotherapy. 
Patients who underwent DIEP flap reconstruction without postmastectomy 
radiotherapy were the control group.
Methods: Participants who had undergone DIEP flap reconstruction between 
September 1, 2009, and September 1, 2014, were recruited, answered the 
BREAST-Q, and underwent three-dimensional surface-imaging. A panel as-
sessed the aesthetic outcome by reviewing these images.
Results: One hundred sixty-seven women participated. Eighty women (48 per-
cent) underwent immediate DIEP flap reconstruction and no postmastectomy ra-
diotherapy; 28 (17 percent) underwent immediate DIEP flap reconstruction with 
postmastectomy radiotherapy; 38 (23 percent) underwent simple mastectomy, 
postmastectomy radiotherapy, and DIEP flap reconstruction; and 21 (13 percent) 
underwent mastectomy with temporizing implant, postmastectomy radiotherapy, 
and DIEP flap reconstruction. Median satisfaction scores were significantly differ-
ent among the groups (p < 0.05). Post hoc comparison demonstrated that women 
who had an immediate DIEP flap reconstruction were significantly less satisfied if 
they had postmastectomy radiotherapy. In women requiring radiotherapy, those 
undergoing delayed reconstruction after a simple mastectomy were most satis-
fied, but there was no significant difference between the immediate DIEP flap 
and temporizing implant groups. Median panel scores differed among groups, 
being significantly higher if the immediate reconstruction was not subjected to 
radiotherapy. There was no significant difference in panel assessment among the 
three groups of women who had received radiotherapy.
Conclusions: Patients who avoid having their immediate DIEP flap reconstruc-
tion irradiated are more satisfied and have better aesthetic outcome than those 
who undergo postmastectomy radiotherapy. In women requiring radiotherapy 
and who wish to have an immediate or “delayed-immediate” reconstruction, there 
were no significant differences in panel or patient satisfaction. Therefore, immedi-
ate DIEP flap reconstruction or mastectomy with temporizing implant then DIEP 
flap surgery are acceptable treatment pathways in the context of post-mastectomy 
radiotherapy. (Plast. Reconstr. Surg. 142: 594, 2018.)
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Breast Reconstruction Audit in 2007 to 2009.2 In 
the United States, 35.5 percent of women undergo 
mastectomy, and rates of immediate breast recon-
struction have increased from 11.6 percent in 
1998 to 36.4 percent in 2011.3
Adjuvant postmastectomy radiotherapy is 
offered to women with risk factors such as T3 to 
T4 disease and/or involved lymph nodes, and its 
local control and survival benefits are well estab-
lished.4–8 More recently, oncologic benefit has 
been demonstrated in women previously consid-
ered to be at “intermediate risk” (i.e., patients 
with N1 disease), such that the criteria for offering 
postmastectomy radiotherapy are expanding.9,10
The deep inferior epigastric artery perforator 
(DIEP) flap, which was first popularized by Allen 
and Treece in 1994,11 has become one of the most 
reliable and popular methods of autologous breast 
reconstruction, with published flap failure rates 
ranging from less than 1 percent to 4 percent.12
Radiotherapy after immediate autologous 
reconstruction has been thought to have a detri-
mental impact on aesthetic outcome; therefore, 
women who are expected to need postmastec-
tomy radiotherapy are often advised to undergo 
a delayed autologous reconstruction.13 The use of 
a temporizing implant, also known as “delayed-
immediate reconstruction,”14,15 allows the patient 
to have a chest wall mound while awaiting the 
planned exchange to autologous reconstruction 
after radiotherapy and facilitates the preserva-
tion of native breast skin. However, this pathway 
has potentially far-reaching consequences. Not 
only does the patient require a subsequent opera-
tion for the reconstruction but she must live for 
a considerable amount of time with a flat chest 
or a tissue expander/implant before the defini-
tive operation. Because of pressures in today’s 
health care system, the waiting time for the elec-
tive reconstruction may be many months.
A systematic review by Kelley et al.12 attempted 
to address questions related to complications and 
flap compromise as a result of radiation delivery 
before or after autologous breast reconstruction. 
The review analyzed 20 articles with over 1500 
flap reconstructions. No significant differences in 
measurable postoperative complications includ-
ing total flap loss, wound healing complications, 
infection, hematoma, seroma, and fat necrosis 
were found when comparing irradiated versus 
unirradiated reconstructions. However, differ-
ences in cosmetic outcome and patient satisfac-
tion between groups were not addressed.
The aim of our study was to investigate aesthetic 
outcome and patient satisfaction in women who 
have undergone DIEP flap reconstruction in the 
setting of postmastectomy radiotherapy. To achieve 
this, we compared patients undergoing immediate 
DIEP flap reconstruction and then radiotherapy 
with women who had radiotherapy after mastec-
tomy (with or without temporizing implant) and 
a delayed DIEP flap. We also studied patients who 
underwent immediate DIEP flap reconstruction 
without radiotherapy as a control group.
PATIENTS AND METHODS 
Recruitment
Regional ethical committee approval was 
obtained and registered. In January of 2016, 
patients who had undergone DIEP flap recon-
struction (immediate or delayed) between Octo-
ber 1, 2009, and October 1, 2014, were identified. 
Exclusion criteria included the following:
• Bilateral DIEP flap reconstruction.
• Delayed reconstruction without postmas-
tectomy radiotherapy.
• Subsequent diagnosis of local recurrence, 
contralateral breast cancer, or metastatic 
disease.
• Subsequent death.
• Less than 1 year after the end of oncologic 
treatment.
• Inability to answer the questionnaire or liv-
ing outside the United Kingdom.
• DIEP flap for chest wall resurfacing rather 
than breast reconstruction.
• DIEP flap for nonbreast cancer abnormal-
ity (e.g., sarcoma).
• DIEP flap for cosmetic failure of other 
reconstruction/breast conservation (e.g., 
poor long-term result after latissimus dorsi 
reconstruction or breast conservation).
• “Salvage” DIEP flap; that is, women in whom 
a definitive implant-based reconstruction 
was planned but, because of urgent com-
plications (e.g., infection or extrusion) or 
severe pain/cosmetic failure caused by cap-
sule formation, the implant was removed 
and replaced with a DIEP flap.
Patients were divided into four groups:
A. Skin-sparing mastectomy with immediate 
DIEP flap reconstruction without postmas-
tectomy radiotherapy (control group).
B. Skin-sparing mastectomy with immediate 
DIEP flap reconstruction and postmastec-
tomy radiotherapy.
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C. Simple mastectomy (no skin preservation), 
postmastectomy radiotherapy, and delayed 
DIEP flap reconstruction.
D. Skin-sparing mastectomy and preservation 
of skin flaps with temporizing implant, 
postmastectomy radiotherapy, and later 
DIEP flap reconstruction.
This cohort largely predates the use of acel-
lular dermal matrices in our unit. If autologous 
reconstruction was the patient’s preference and 
radiotherapy was anticipated, our usual practice 
was to offer a temporizing implant (in the form of 
a subpectoral expandable implant) and replace-
ment with a DIEP flap 12 months or more after 
postmastectomy radiotherapy. Toward the end of 
the inclusion period, we began to offer immediate 
DIEP flap reconstruction to selected women who 
were likely to require radiotherapy because it was 
anecdotally noted that women who had under-
gone immediate DIEP flap reconstruction and 
then unexpectedly needed radiotherapy had a 
good cosmetic outcome. Patients were counseled 
before surgery of the potential effect of radiother-
apy to an immediate DIEP flap reconstruction, and 
those who were willing to accept this rather than a 
delayed approach were considered for an immedi-
ate reconstruction. In particular, patients with large 
breasts were felt to have little to gain from a tempo-
rizing implant approach because of the resulting 
asymmetry after a delayed DIEP flap and require-
ment for a contralateral symmetrizing procedure; 
therefore, these patients began to be considered 
for immediate reconstruction despite the need 
for radiotherapy. In the simple mastectomy group, 
the lower pole skin is usually found to constrict the 
potential envelope and is excised, to be replaced by 
more compliant skin from the abdomen.
Postmastectomy radiotherapy was delivered to 
the chest wall with or without the reconstructed 
breast with or without the supraclavicular fossa to a 
dose of 40 Gy in 15 fractions over 3 weeks. A simple 
forward-planned intensity-modulated field-based 
technique was used in which the chest wall was 
treated with tangential fields (with dose homog-
enization using a step-and-shoot technique) and 
the supraclavicular fossa with a matched anterior 
field. Only in cases with involved anterior mar-
gins or inflammatory breast cancer was skin bolus 
(1 cm thickness) applied to the chest wall with or 
without the reconstructed breast for all 15 frac-
tions. In all other cases, bolus was not applied.
Eligible patients were invited to participate 
by letter. Participants underwent medical photog-
raphy using the Vectra XT (Canfield Scientific, 
Fairfield, N.J.) three-dimensional surface imag-
ing system and completed the BREAST-Q recon-
struction module.16–18 The clinicopathologic data 
set was collected independently from the patient 
satisfaction and panel assessment results. Compli-
cation data were collected only for breast compli-
cations (not donor site).
Patient-Reported Satisfaction
The BREAST-Q is a validated patient-reported 
outcome measurement tool that is specifically 
designed to measure satisfaction and quality of life 
in women who have undergone breast reconstruc-
tion. For this study, the first domain, “Satisfaction 
with Breasts,” was used. Within this domain are 16 
subquestions answered according to a four-point 
Likert scale. The total score is transformed into a 
score out of 100. The higher the score, the more 
satisfied the patient reports to be.
Surgeon-Reported Aesthetic Outcome
A panel assessment of aesthetic outcome 
was undertaken. The three-dimensional image 
was rotated so it could be viewed from all angles 
(Fig. 1). The 10-point score by Visser et al.19 
was used, as it was rated best in a review article 
comparing panel assessments for breast recon-
struction using the modified Scientific Advisory 
Committee’s Medical Outcomes Trust Criteria20 
and has been used in several other published stud-
ies.21–29 In this scoring system, volume, shape, sym-
metry, scarring, and nipple-areola complex are 
scored from 1 to 5, and a global score from 1 to 
10 is assigned to each patient, whereby a higher 
total score indicates a better aesthetic outcome. 
The panel consisted of two plastic surgeons and 
two breast surgeons. The panel members scored 
independently, and the median score was used in 
the analysis. The panel members were blinded to 
which treatment arms the patients were in.
Statistical Analysis
Demographics were presented as descriptive 
statistics, and any quantitative variables were pre-
sented as mean and standard deviation or median 
and interquartile range, as appropriate after testing 
for normality. Qualitative data were presented as 
proportions and frequencies, and the chi-square or 
Fisher’s exact test was used to compare the groups.
A kappa statistic was used to assess the inter-
rater agreement between the surgeons assessing 
aesthetic outcome in the panel assessment. A value 
of 0 indicates no agreement, 0 to 0.20 is slight agree-
ment, 0.21 to 0.40 is fair agreement, 0.41 to 0.60 
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is moderate agreement, 0.61 to 0.80 is substantial 
agreement, is 0.81 to 1 is almost perfect agreement.
After testing for normality, the Kruskal-Wallis 
test was used to assess the relationship of patient 
satisfaction and panel score of aesthetic outcome 
with the patient treatment group (1 through 4). 
The Dunn-Sidak test (a post hoc adjusted pair-
wise comparison) was used to identify between 
which pairs of treatment groups the significant 
differences lay. Any pairwise comparisons with 
a value of p < 0.05 were considered statistically 
significant. Analysis was performed using Stata 
(StataCorp, College Station, Texas).
RESULTS
Between October 1, 2009, and October 
1, 2014, 476 women underwent DIEP flap 
Fig. 1. Images produced using the three-dimensional imaging system include (above, left) anteroposte-
rior, (above, right) lateral, (center, left) craniocaudal, (below, right) oblique, and (below, left) caudocranial.
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reconstruction. There were no flap losses in the 
cohort. One hundred seventy-seven women were 
not eligible because of bilateral surgery (n = 22), 
delayed reconstruction without postmastectomy 
radiotherapy (n = 42), less than 1 year after the 
end of oncologic treatment (n = 5), local recur-
rence (n = 5), contralateral breast cancer (n = 4), 
metastatic disease (n = 15), died (n = 12), unable 
to answer questionnaire or live outside the United 
Kingdom (n = 40), sarcoma (n = 5), previous latis-
simus dorsi reconstruction (n = 5), poor result 
from previous breast conservation therapy (n = 1), 
chest wall resurfacing (n = 1), or salvage DIEP 
flap reconstruction (n = 18). It was not possible 
to contact 101 women and 30 declined to partici-
pate. Three women did not attend the arranged 
appointment. Therefore, in total, 167 women par-
ticipated in the study (Fig. 2).
Table 1 demonstrates the clinicopathologic 
features of each group according to radiotherapy 
and timing of surgery. The patient characteristics 
were broadly similar in the four groups. There was 
a significant difference between the groups when 
comparing time from surgery to participation in 
the study; it was shortest for group B (immediate 
reconstruction with postmastectomy radiother-
apy). Recently, more patients have undergone 
immediate reconstruction and then radiotherapy, 
as the team is offering immediate reconstruction 
to selected women who require adjuvant radio-
therapy, and simultaneously the indications for 
radiotherapy have become broader. As expected, 
participants in group A (no postmastectomy radio-
therapy) had significantly lower rates of chemo-
therapy and endocrine therapy because they had 
ductal carcinoma in situ or less advanced invasive 
disease.
Panel Assessment
The weighted kappa agreement between the 
four assessors in the panel assessment was “moder-
ate” (0.4) for the global score. For the subcatego-
ries, the weighted kappa agreements were “slight” 
for nipple-areola appearance (0.2) and scar-
ring (0.29), and “fair” for volume (0.31), shape 
(0.36), and symmetry (0.38). Because of the low 
agreement in the subcategories, only the global 
score was used in further analysis. Figure 3 dem-
onstrates an image of a typical patient from each 
patient pathway.
The median global panel scores were signifi-
cantly different when the patients were divided 
according to the treatment pathway (p = 0.001, 
Kruskal-Wallis test) (Table 2 and Fig. 4). Post hoc 
pairwise comparisons demonstrated that the panel 
gave a significantly worse score to an irradiated 
Fig. 2. Diagram of recruitment.
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immediate DIEP flap reconstruction (group B) 
than to an unirradiated DIEP flap reconstruc-
tion (group A controls). However, there were no 
differences in median panel scores among groups 
B, C, and D, all of whom received postmastectomy 
radiotherapy (Table 3).
Table 1. Clinicopathologic Data According to the Four Participant Groups and the Total
Clinicopathologic Characteristics
Group A:  
Control  
Group (%)
Group B:  
Immediate 
DIEP and  
PMRT (%)
Group C:  
Simple  
Mastectomy,  
PMRT, and  
Delayed DIEP (%)
Group D:  
Mastectomy  
and TI, PMRT, 
and Delayed  
DIEP (%) Total p
Patient characteristics       
  No. 80 (47.9) 28 (16.8) 38 (22.8) 21 (12.5) 167  
  Age at diagnosis, yr      0.128*
   Median 52.8 54.9 46.9 46.6 50.7  
   IQR 49–60.3 48.6–60.7 42.7–51.6 43.5–50.4 45.4–56.7  
  Age at participation, yr      0.144*
   Median 56.8 57.8 54.3 50.8 55.9  
   IQR 52.3–64.5 51.7–63.1 49.3–59.8 48–54.7 50.7–62.5  
  BMI, kg/m2      0.093*
   Median 24.6 27.6 26.8 25.6 25.7  
   IQR 22.5–28.6 23.5–29.3 24.7–29.4 22.6–28.6 23.2–28.9  
  Smoking      0.147†
   Current 4 (5) 0 1 (2.6) 0 5 (3)  
   Ex-smoker 31 (38.8) 9 (32.4) 14 (36.9) 14 (66.7) 68 (40.7)  
   Never 45 (56.2) 19 (67.6) 23 (60.5) 7 (33.3) 94 (56.3)  
  Diabetes 3 (3.8) 0 1 (2.6) 0 4 (2.4) 0.606†
  Ethnic origin      0.241†
   White 76 (95) 27 (96.4) 35 (92.1) 20 (95.2) 158 (94.6)  
   Other 4 (5) 1 (3.6) 3 (7.9) 1 (4.8) 9 (5.4)  
  Time from DIEP surgery to  
participation, mo      0.002*‡
   Median 48.7 27.5 50.3 41.2 44.3  
   IQR 35.9–54.4 22.8–42.2 37.1–61.2 34.5–50.8 31.1–56.4  
Intraoperative data       
  Flap weight, g      0.002*‡
   Median 513 580 674.5 604 585  
   IQR 400–685 428–762 582.5–879 500–915 444–750  
  Ischemic time, min      0.384*
   Median 58 49 59 55.5 56  
   IQR 45–69 42–66 50–70 42.5–66.5 45–69  
  Time from mastectomy to DIEP, mo      <0.001†‡
   Median NA NA 30.7 12.6 NA  
   IQR NA NA 20.4–43.9 8.8–15.4 NA  
Oncologic treatment       
  Chemotherapy 19 (23.8) 22 (78.6) 36 (94.7) 19 (90.5) 96 (57.5) <0.001†‡
  Endocrine therapy 40 (50) 23 (82.1) 30 (79) 17 (80.9) 110 (65.9) <0.001†‡
  PMRT 0 28 (100) 38 (100) 21 (100) 87 (52.1) <0.001†‡
Complications (breast only)       
  Emergency return to operating room, 
breast hematoma/ischemia 3 (3.8) 0 1 (2.6) 0 4 (2.4) 0.540†
  Infection 3 (3.8) 3 (10.7)) 2 (5.3)) 2 (9.5) 10 (6) 0.237†
  Fat necrosis requiring surgical excision 2 (2.5) 1 (3.6) 2 (5.3) 1 (4.8) 6 (3.6) 0.686†
  Breast seroma requiring drainage 3 (3.8) 3 (10.7) 0 1 (4.8) 7 (4.2) 0.196†
  Delayed wound healing§ 9 (11.6) 4 (14.3) 7 (18.4) 3 (14.3) 23 (13.8) 0.770†
Further elective surgery       
  Contralateral surgery 21 (26.3) 8 (28.6) 20 (52.6) 7 (33.2) 56 (33.5) 0.038†‡
  Reconstructed breast adjustments  
(excluding nipple reconstruction) 44 (55) 16 (57.1) 26 (68.4) 14 (66.7) 100 (59.9) 0.487†
  No. of reconstructed breast adjustments      NA
   0 36 (45) 12 (42.9) 12 (31.6) 7 (33.3) 67 (40.1)  
   1 33 (41.3) 12 (42.9) 15 (39.5) 8 (38.1) 68 (40.7)  
   2 8 (10) 3 (10.7) 10 (26.3) 5 (23.8) 26 (15.6)  
   3 3 (3.7) 1 (3.6) 1 (2.6) 1 (4.8) 6 (3.6)  
  Nipple reconstruction 60 (75) 16 (57.1) 29 (76.3) 15 (71.1) 120 (71.9) 0.592†
PMRT, postmastectomy radiotherapy; TI, temporizing implant; IQR, interquartile range; BMI, body mass index.
*Kruskal-Wallis test.
†χ2 test.
‡Indicates significant values of p < 0.05.
§Documented non–fully healed wound 30 days or more after surgery.
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Patient Satisfaction
The median satisfaction with breasts scores 
were significantly different between some groups 
(p = 0.002, Kruskal-Wallis test) (Table 2 and Fig. 5). 
Post hoc pairwise comparison again demonstrated 
a significant difference according to whether post-
mastectomy radiotherapy was administered to 
an immediate DIEP flap reconstruction. Among 
women who had undergone radiotherapy, those 
who had an irradiated immediate reconstruction 
(group B) had significantly lower satisfaction than 
those who underwent delayed DIEP flap surgery 
after simple mastectomy (group C). There was 
no significant difference between immediate 
Fig. 3. Representative images from each of the four groups. Please note that the panel assessed moving three-dimen-
sional images not the two-dimensional images shown here. (Above, left) Patient with a score of 8.5 from group A: 
skin-sparing mastectomy with immediate DIEP flap reconstruction without postmastectomy radiotherapy (median 
score, 8). (Above, right) Patient with a score of 7.25 from group B: skin-sparing mastectomy with immediate DIEP flap 
reconstruction and postmastectomy radiotherapy (median score, 7.3). (Below, left) Patient with a score of 7.0 from 
group C: simple mastectomy (no skin preservation), postmastectomy radiotherapy, and delayed DIEP flap recon-
struction (median score, 7.3). (Below, right) Patient with a score of 7.75 from group D: skin-sparing mastectomy and 
preservation of skin flaps with temporizing implant, postmastectomy radiotherapy, and later DIEP reconstruction 
(median score, 7.8). 
Table 2. Median Global Panel Scores and Satisfaction 
with Breasts According to Surgical Pathway
Surgical  
Pathway No.
Median  
Global Panel 
Score (IQR)
Median  
Satisfaction  
with Breasts (IQR)
A* 79 8 (7–9) 75 (65–85)
B† 27 7.3 (6.1–7.8) 64 (53–73)
C‡ 38 7.3 (6.8–8) 81 (69–91)
D§ 21 7.8 (6.5–8) 75 (59–85)
Combined 165 7.5 (6.8–8.5) 73 (62–85)
IQR, interquartile range; PMRT, postmastectomy radiotherapy; TI, 
temporizing implant.
*Immediate DIEP, control group.
†Immediate DIEP and postmastectomy radiotherapy.
‡Mastectomy, postmastectomy radiotherapy, and DIEP.
§Mastectomy, temporizing implant, postmastectomy radiotherapy, 
and DIEP.
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reconstruction with radiotherapy (group B) and 
mastectomy with temporizing implant, radio-
therapy, and then DIEP flap surgery (group D) 
(Table 3).
DISCUSSION
The timing of autologous reconstruction in 
the context of a predicted need for postmastec-
tomy radiotherapy poses a challenge to breast and 
plastic surgeons. This study has demonstrated that 
irradiating an immediate DIEP flap reconstruc-
tion does have a detrimental effect on aesthetic 
outcome as judged by a panel of surgeons and by 
patients themselves in their response to the Sat-
isfaction with Breasts domain of the BREAST-Q 
questionnaire.
However, for those women who required post-
mastectomy radiotherapy, there was no significant 
difference in panel assessment of aesthetic out-
come between immediate DIEP flap reconstruc-
tion with radiotherapy, simple mastectomy with 
radiotherapy then delayed DIEP flap surgery, or 
mastectomy and temporizing implant with radio-
therapy and then conversion to DIEP flap surgery. 
Patient-reported outcomes did show differences, 
with women undergoing delayed reconstruction 
after a simple mastectomy the most satisfied, 
but there was no significant difference between 
women with an irradiated immediate DIEP flap 
reconstruction and those who had undergone 
mastectomy with temporizing implant, postmas-
tectomy radiotherapy, and later DIEP flap sur-
gery. It is known that women who have a delayed 
Fig. 4. Box-and-whisker plot demonstrating global panel assessment scores according to 
different treatment pathways. The horizontal line through the center of each box represents 
the median score, outer horizontal lines of each box represents upper and lower quartiles, 
and the ends of the vertical lines represent minimum and maximum scores. There was a 
significant difference between A and B. imm, immediate; PMRT, postmastectomy radio-
therapy; mx, mastectomy; TI, temporizing implant.
Table 3. Pairwise Comparisons of Median Global Panel Scores and Satisfaction with Breasts According to 
Surgical Pathway (p Values)
Surgical Pathway
Values for Post Hoc Pairwise 
Comparisons for Medial  
Global Panel Score (p)
Values for Post Hoc Pairwise 
Comparisons for Median  
Satisfaction with Breasts (p)
Comparison of immediate reconstruction with  
and without PMRT   
  A vs. B 0.001*† 0.008*† 
Comparison of treatment pathways if PMRT is required   
  B vs. C 0.626 0.0004*‡ 
  B vs. D 0.515 0.284
  C vs. D 0.809 0.188
PMRT, postmastectomy radiotherapy.
*Statistically significant (p < 0.05).
†In favor of A.
‡In favor of C.
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reconstruction report high levels of satisfaction 
because they have been living with a flat chest wall, 
whereas women who undergo immediate recon-
struction are comparing their reconstruction 
with their natural breast.30 Furthermore, many 
women who received radiotherapy to their DIEP 
flap were not expected to require adjuvant radio-
therapy. This disappointment may be reflected in 
the satisfaction scores whether or not there was 
a substantial change in the reconstruction after 
radiotherapy. These results demonstrate one of 
the potential pitfalls of using patient-reported 
outcomes to compare patients who have taken 
a different treatment pathway to reach the same 
endpoint.
Women who are offered a temporizing implant 
are often those who would ideally like to undergo 
immediate autologous reconstruction but have 
been advised to delay the use of their autologous 
flap until after radiotherapy, and thus are the 
most relevant comparator group to the irradiated 
DIEP flap cohort. The finding that there is no sig-
nificant difference between these two groups in 
terms of patient satisfaction or panel assessment 
suggests that these are both reasonable treatment 
pathways as far as patient satisfaction and cosmetic 
outcome are concerned.
There is a paucity of data on the aesthetic 
impact of irradiating autologous reconstructions 
in the literature. Early studies of transverse rec-
tus abdominis myocutaneous and DIEP flaps 
concluded that radiotherapy had resulted in an 
increase in late complications and requirement 
for reoperation, and had a negative impact on 
aesthetic appearance, symmetry, contracture, and 
hyperpigmentation of the skin.31–34 Similarly, ini-
tial studies of patient-reported aesthetic outcome 
lacked a comparator group35,36 or included small 
numbers of women and a wide variety of breast 
reconstruction techniques.37 Although these early 
studies involved relatively few patients, they estab-
lished the mindset that irradiating an autologous 
abdominal flap gives unacceptable results and 
that delayed reconstruction is preferable.
However, plastic surgical techniques continue 
to improve, and DIEP flaps have become routine, 
largely replacing transverse rectus abdominis myo-
cutaneous flaps. Careful planning38 and maneuvers 
designed to improve flap design and circulation 
are all likely to protect against radiotherapy toxic-
ity. Simultaneously, advances in postmastectomy 
radiotherapy planning, fractionation, and delivery 
directed at reducing dose heterogeneity and dam-
age to normal tissues contribute to a lower impact 
on autologous flaps than has previously been 
reported. The literature is beginning to reflect this, 
with a meta-analysis of outcome and a systematic 
review of patient satisfaction both reporting accept-
able outcomes.39,40 Clarke-Pearson et al.41 carried 
out the most direct comparison, reporting on post-
operative photographs of 11 cases of bilateral DIEP 
reconstruction with unilateral postmastectomy 
radiotherapy. They found good aesthetic outcome 
with satisfactory preservation of breast shape and 
Fig. 5. Box-and-whisker plot demonstrating Satisfaction with Breasts according to different 
treatment pathways. The horizontal line through the center of each box represents median 
score, outer horizontal lines of each box represent upper and lower quartiles, and the ends 
of the vertical lines represent minimum and maximum scores. There was a significant differ-
ence between A and B, and B and C. imm, immediate; PMRT, postmastectomy radiotherapy; 
mx, mastectomy; TI, temporizing implant.
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minimal change in flap consistency on manual 
compression (by the patient in the photograph). A 
recent study from China demonstrated that radia-
tion and its timing did not have an adverse impact 
on patients’ aesthetic and psychological evalua-
tions by the BREAST-Q questionnaire. In fact, they 
found that there was no significant difference in 
satisfaction whether the patient underwent imme-
diate reconstruction with radiotherapy or a delayed 
reconstruction after radiotherapy.42
The advantage of our study was that it is rela-
tively large and the pairwise comparisons were 
made to answer clinical questions. This allowed 
separate comparison of the impact of postmas-
tectomy radiotherapy on an immediate DIEP flap 
reconstruction (A versus B) and of the final out-
comes in women who underwent radiotherapy 
with a variety of reconstructive surgery pathways 
(B versus C versus D). The latter will aid decision-
making for women requiring radiotherapy as to 
whether to choose an immediate or delayed recon-
struction with or without a temporizing implant.
Although the number of participants in the 
subgroups was small and the study was retrospec-
tive, it gives weight to the argument that autolo-
gous reconstruction can be considered even when 
postmastectomy radiotherapy is anticipated. It was 
disappointing that the agreement among the panel 
raters was low for the subcomponents of the aes-
thetic outcome and therefore was not used in the 
analysis of the results. After careful consideration 
with statisticians, it was decided that the moder-
ate agreement of the global score was sufficient to 
take forward to the analysis. We believe that hav-
ing the opinion of the surgeons in addition to the 
patient-reported outcome measures is important 
to help provide an unbiased opinion of the recon-
struction. The psychological impact of undergoing 
cancer treatment, premorbid psychological state, 
and treatment pathway factors (i.e., going from flat 
chest to reconstruction versus going from native 
breast to reconstruction) to which the patients are 
exposed are likely to impact on their satisfaction.
If the option of immediate reconstruction is 
offered to more women who are expected to have 
postmastectomy radiotherapy, the surgeon is able to 
counsel women about the likely changes and man-
age their expectations, and can take measures such 
as making the reconstruction larger to mitigate 
against volume loss from radiation-induced fibrosis. 
Thus, if this becomes routine, patient satisfaction 
with the outcome may be better than in this study.
CONCLUSIONS
This study has demonstrated that postmas-
tectomy radiotherapy to an immediate DIEP flap 
reconstruction does have a detrimental effect on 
aesthetic outcome as judged by a panel of surgeons 
and by patients themselves. There was no significant 
difference in panel assessment among the three 
treatment pathways in women who required post-
mastectomy radiotherapy, whereas women under-
going delayed reconstruction reported greatest 
satisfaction. The lack of a difference in patient sat-
isfaction and global panel assessment between the 
irradiated immediate DIEP flap reconstruction and 
the mastectomy with temporizing implant groups 
suggests that a careful and individualized discussion 
must take place such that women are able choose 
between the two options, both of which have ben-
efits and disadvantages, according to their own pri-
orities and the surgeon’s judgment on suitability.
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